Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Pulmonary Hypertension

  Free Subscription


02.02.2026

1 Am J Physiol Lung Cell Mol Physiol
1 ASAIO J
1 Biomolecules
1 BMJ Paediatr Open
1 Bull Exp Biol Med
1 Cells
1 Chest
2 Circulation
1 Clin Rheumatol
1 Compr Physiol
1 Eur Heart J
2 Eur Heart J Cardiovasc Imaging
3 Free Radic Biol Med
1 Front Artif Intell
1 Front Cardiovasc Med
3 Front Med (Lausanne)
1 Front Pharmacol
1 Heart Lung
1 Hum Exp Toxicol
1 Int J Cardiovasc Imaging
4 Int J Mol Sci
1 J Cardiothorac Surg
1 Mediterr J Rheumatol
1 Pediatr Cardiol
1 Physiol Rep
2 Pol Arch Intern Med
3 Pulm Circ
1 Sci Rep
1 Vet Med Sci
1 World J Cardiol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Physiol Lung Cell Mol Physiol

  1. BHADRA A, Bonnie F, Hewes J, Patel M, et al
    cAMP-enriched extracellular vesicles improve outcomes in pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2026;330:L169-L177.
    PubMed         Abstract available


    ASAIO J

  2. ELSABAN M, Radosevich MA, Pennington KM, Spencer PJ, et al
    Cardiac Arrest in the Setting of Left Lung Herniation Following Combined Heart-Lung Transplant: Case Report.
    ASAIO J. 2025;71:e168-e171.
    PubMed         Abstract available


    Biomolecules

  3. YOKOYAMA YM, Watanabe R, Yamaguchi T, Ishihara R, et al
    Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Current Therapeutic Strategies and Future Prospects.
    Biomolecules. 2026;16:140.
    PubMed         Abstract available


    BMJ Paediatr Open

  4. OKECHUKWU A, Odetunde O, Uchenna E, Chinawa JM, et al
    Prevalence and severity of persistent pulmonary hypertension of the newborns among asphyxiated neonates admitted in Enugu State University Teaching Hospital.
    BMJ Paediatr Open. 2026;10:e004351.
    PubMed         Abstract available


    Bull Exp Biol Med

  5. REVENKO SV, Tarakanov IA, Tikhomirova LN, Kuropatkina TA, et al
    Effect of Hindlimb Denervation on Survival Rate and Circulation and Respiration Systems in Monocrotaline Rat Model of Pulmonary Arterial Hypertension.
    Bull Exp Biol Med. 2025;179:644-649.
    PubMed         Abstract available


    Cells

  6. SUEBLINVONG V, Chang SS, Ma J, Archer DR, et al
    Long Non-Coding RNA MALAT1 Regulates HMOX1 in Sickle Cell Disease-Associated Pulmonary Hypertension.
    Cells. 2026;15:154.
    PubMed         Abstract available


    Chest

  7. CHANDEL A, Turkington S, King CS, Singhal A, et al
    Pulmonary hypertension prevalence and significance in lung transplant recipients with cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Chest. 2026 Jan 27:S0012-3692(26)00127-3. doi: 10.1016/j.chest.2025.
    PubMed         Abstract available


    Circulation

  8. TADA A, Fayyaz AU, Reddy YNV, Redfield MM, et al
    Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution.
    Circulation. 2026;153:285-289.
    PubMed        

  9. TORO V, Mougin M, Brossat C, Jambon-Barbara C, et al
    Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
    Circulation. 2026 Jan 28. doi: 10.1161/CIRCULATIONAHA.125.079067.
    PubMed         Abstract available


    Clin Rheumatol

  10. QASEM U, Alghwyeen W, Alshqeirat M, Saman R, et al
    Unveiling pleuropulmonary manifestations in systemic lupus erythematosus: a retrospective observational study from the Middle East.
    Clin Rheumatol. 2026;45:151-162.
    PubMed         Abstract available


    Compr Physiol

  11. LECHUGA CG, Kachabi A, Colebank MJ, Korcarz CE, et al
    Patient-Specific Lumped-Parameter Model for Quantifying Vessel-Specific Remodeling and Predicting Right Ventricular Function in Pulmonary Hypertension.
    Compr Physiol. 2026;16:e70102.
    PubMed         Abstract available


    Eur Heart J

  12. ZHANG H, Guo X, Han Y
    A tale of two forces: pulmonary hypertension and hepatopulmonary syndrome in congenital portosystemic shunt.
    Eur Heart J. 2026 Jan 13:ehaf820. doi: 10.1093.
    PubMed        


    Eur Heart J Cardiovasc Imaging

  13. VENKATESHVARAN A, Lindqvist P, Evaldsson AW
    Right Ventricular Global Wasted Work: Employing Myocardial Energetics for Risk Assessment and Outcome Prediction in Pulmonary Hypertension.
    Eur Heart J Cardiovasc Imaging. 2026 Jan 28:jeag029. doi: 10.1093.
    PubMed        

  14. BERTHELOT E, Bauer F, Fauvel C, Paclot M, et al
    Echocardiographic Risk Stratification in Heart Failure with Post-Capillary Pulmonary Hypertension: Prognostic Value of LAVI and TAPSE/PASP.
    Eur Heart J Cardiovasc Imaging. 2026 Jan 30:jeag034. doi: 10.1093.
    PubMed         Abstract available


    Free Radic Biol Med

  15. JIAO Q, Yang Y, Xu X, Hao J, et al
    Therapeutic potential of magnesium diboride nanosheets in PAH-associated right heart failure: Integrated multi-omics analysis reveals ferroptosis suppression via LC3/ATG5/NCOA4/FTH1 pathway.
    Free Radic Biol Med. 2026;244:1-16.
    PubMed         Abstract available

  16. OU L, Chen Y, Shen A, He S, et al
    Epigenetically activated MIR100HG regulates UPF1-mediated oxidative stress to promote pulmonary vascular immune microenvironment remodeling.
    Free Radic Biol Med. 2026;244:210-228.
    PubMed         Abstract available

  17. CHEN H, Qiu YX, Xie YF, Chen X, et al
    Redox switch C674 in SERCA2 triggers Ca(2+)-calcineurin-MCU-Drp1 cascade and pulmonary vascular remodeling.
    Free Radic Biol Med. 2026;244:380-394.
    PubMed         Abstract available


    Front Artif Intell

  18. AHMED F, Haider F, Ali R, Arham M, et al
    Comparative accuracy of artificial intelligence versus manual interpretation in detecting pulmonary hypertension across chest imaging modalities: a diagnostic test accuracy meta-analysis.
    Front Artif Intell. 2026;8:1709489.
    PubMed         Abstract available


    Front Cardiovasc Med

  19. RONG C, Zhang L, Li B, Wang Y, et al
    Efficacy and safety of specific treatment combined with SGLT2-i in pulmonary hypertension.
    Front Cardiovasc Med. 2026;12:1684394.
    PubMed         Abstract available


    Front Med (Lausanne)

  20. WANG H, Cui M
    Effects of balloon pulmonary angioplasty on cardiac and pulmonary functions and complications in patients with chronic thromboembolic pulmonary hypertension.
    Front Med (Lausanne). 2026;12:1689193.
    PubMed         Abstract available

  21. SHEN T, Lv X, Wang C, Ma Q, et al
    Severe pulmonary edema after pulmonary hypertension interventional surgery: case report and literature review.
    Front Med (Lausanne). 2026;12:1723147.
    PubMed         Abstract available

  22. ALTURAIF N, Alduraibi FK, Marquez K, Alahmadi F, et al
    Pulmonary endarterectomy in antiphospholipid syndrome: a retrospective analysis from the Saudi pulmonary hypertension registry.
    Front Med (Lausanne). 2026;13:1736115.
    PubMed         Abstract available


    Front Pharmacol

  23. MA J, Cao X, Yang X, Zhu Y, et al
    Natural products targeting the immune-metabolic regulatory network in pulmonary hypertension: mechanisms, classification, and therapeutic prospects.
    Front Pharmacol. 2026;16:1712903.
    PubMed         Abstract available


    Heart Lung

  24. LU Z, Zhang C, Wan J, Xiao Y, et al
    Exercise tolerance in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.
    Heart Lung. 2026;78:102725.
    PubMed         Abstract available


    Hum Exp Toxicol

  25. LIANG S, Wang X, Wu Y
    Establishment of a rat model of bronchopulmonary dysplasia complicated with pulmonary hypertension and its potential applications.
    Hum Exp Toxicol. 2026;45:9603271261420421.
    PubMed         Abstract available


    Int J Cardiovasc Imaging

  26. YU L, Hou Z, Han L, An Y, et al
    Clinical and imaging characteristics of pulmonary artery dissection.
    Int J Cardiovasc Imaging. 2026;42:111-117.
    PubMed         Abstract available


    Int J Mol Sci

  27. TILEA I, Iancu DG, Fira-Mladinescu O, Bertici N, et al
    Sotatercept in Pulmonary Arterial Hypertension: Molecular Mechanisms, Clinical Evidence, and Emerging Role in Reverse Remodelling.
    Int J Mol Sci. 2026;27:767.
    PubMed         Abstract available

  28. BATUM O, Ayik Turk M, Varol Y, Ozyilmaz B, et al
    Genetic and Clinical Determinants of Chronic Thromboembolic Pulmonary Hypertension: The Role of PAI-1 Polymorphism.
    Int J Mol Sci. 2026;27:758.
    PubMed         Abstract available

  29. MILANO G, Ottolenghi S, Zubieta-Calleja G, Beghetti M, et al
    Mechanisms Underlying Altitude-Induced and Group 3 Pulmonary Hypertension.
    Int J Mol Sci. 2026;27:572.
    PubMed         Abstract available

  30. SCAGLIOLA R
    Deciphering the Counterintuitive Role of Vascular Endothelial Growth Factor Signaling Pathways in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2026;27:687.
    PubMed         Abstract available


    J Cardiothorac Surg

  31. YOKAWA K, Kawakami M, Tanaka Y, Higuma T, et al
    Acute pulmonary hypertension induced by heparin-protamine complex during thoracoabdominal aortic grafting.
    J Cardiothorac Surg. 2026 Jan 24. doi: 10.1186/s13019-025-03807.
    PubMed        


    Mediterr J Rheumatol

  32. BAISYA R, Vardhan YK, Gsr M, Vardhan YV, et al
    The Long-Term Outcomes of Pulmonary Hypertension in Systemic Lupus Erythematosus (SLE-PAH) Vary Among Different Autoantibody-Based Clusters: An Observational, Longitudinal Study Conducted at a Single Centre in India.
    Mediterr J Rheumatol. 2025;36:594-599.
    PubMed         Abstract available


    Pediatr Cardiol

  33. HAYVACI CANBEYLI F, Secgen K, Ezgu FS, Tacoy G, et al
    The Role of Genetics in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
    Pediatr Cardiol. 2026;47:821-829.
    PubMed         Abstract available


    Physiol Rep

  34. GARCIA SM, Lantz BJ, Wagner HJ, Jones DT, et al
    Inducible Ift88-deficient mice show features consistent with mild pulmonary hypertension.
    Physiol Rep. 2026;14:e70749.
    PubMed         Abstract available


    Pol Arch Intern Med

  35. NIEMIEC M, Grabka M, Niemiec R, Filipecki A, et al
    Designing the right trial for sacubitril / valsartan in heart failure with preserved ejection fraction-related pulmonary hypertension. Authors' reply.
    Pol Arch Intern Med. 2026;136:17212.
    PubMed        

  36. PAGNONI G, Vicenzi A, Coppi F
    Designing the right trial for sacubitril / valsartan in heart failure with preserved ejection fraction-related pulmonary hypertension.
    Pol Arch Intern Med. 2026;136:17211.
    PubMed        


    Pulm Circ

  37. SU H, Li B, Guo Z, Zhang F, et al
    Beta-Alanine Supplementation Ameliorates Right Ventricular Remodeling Caused by Monocrotaline-Induced Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70244.
    PubMed         Abstract available

  38. HUANG Y, Qin B, Shen B, Zhu J, et al
    Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: A Comparative Study of Biomarkers and Clinical Indicators.
    Pulm Circ. 2026;16:e70228.
    PubMed         Abstract available

  39. CHILINGARASHVILI G, Mylvaganam RJ, Bernardo RJ, Shah A, et al
    Sotatercept in Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension: A Case Series and Systematic Review.
    Pulm Circ. 2026;16:e70239.
    PubMed         Abstract available


    Sci Rep

  40. KRONBERGER C, Mousavi RA, Ermolaev N, Poledniczek M, et al
    Performance on the one-minute sit-to-stand test predicts long-term adverse outcomes in pulmonary hypertension.
    Sci Rep. 2026 Jan 29. doi: 10.1038/s41598-026-37611.
    PubMed        


    Vet Med Sci

  41. AHMADIPOUR B, Pat S, Khajali F, Hassanpour H, et al
    Effects of Sodium Butyrate Forms on Carcass Performance, Pulmonary Hypertension, Metabolic Health and Oxidative-Inflammatory Responses in Broiler Chickens Under Cold Stress at High Altitude.
    Vet Med Sci. 2026;12:e70720.
    PubMed         Abstract available


    World J Cardiol

  42. KUMAR P, Verma AK, Bajpai J, Kar SK, et al
    Pulmonary hypertension in patients with obstructive sleep apnea: Correlation with disease severity and quality of life.
    World J Cardiol. 2026;18:112541.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.